Clinical Trials
6,911 trialsA Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
AstraZeneca
Bridge CRC
University of Illinois at Chicago
FORTITUDE-101
Amgen
ASPIRES
Ann & Robert H Lurie Children's Hospital of Chicago
Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer
Fudan University
HER Image
Amsterdam UMC, location VUmc
A Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic Cancer
Wuhan YZY Biopharma Co., Ltd.
Effect of Silkworm Pupa Tablets in Gastrointestinal Malignancies at Nutritional Risk Following Radical Surgery
First Affiliated Hospital of Zhejiang University
Erector Spinae Plane Block in Laparoscopic Colorectal Cancer Surgery
Kayseri City Hospital
MK-4280A-007
Merck Sharp & Dohme LLC
CHORDA-II-p
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
X-CLOSURE
Islamabad Medical and Dental College
Assessment of Safety, Quality, and Acceptance of a Bowel Preparation Using a Food Kit With Laxatives
Hunter Holmes Mcguire Veteran Affairs Medical Center
FORBES
Sun Yat-sen University
RECT
University Hospital, Bordeaux
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer
Emory University
A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer
Changchun GeneScience Pharmaceutical Co., Ltd.
A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute
BRIDGE-GC
The Catholic University of Korea
FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)
Icahn School of Medicine at Mount Sinai
PACE
UNC Lineberger Comprehensive Cancer Center
SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study
SafeHeal Inc
Evaluation of Colonic Perfusion by Indocyanine Green Angiography During Colorectal Surgery
University of Roma La Sapienza
SBS-CEUS
The First Hospital of Jilin University
A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma
SillaJen, Inc.
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Alliance for Clinical Trials in Oncology
Effects of Epidural Anesthesia and Analgesia on the Prognosis in Patients Undergoing Pancreatic Cancer Surgery
Fudan University
DISRUPT
Icahn School of Medicine at Mount Sinai
Phase IIT Trial of SNA009
SmartNuclide Biopharma
A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers
Massachusetts General Hospital
ELEVATE
University of Southampton
SCORE
UNC Lineberger Comprehensive Cancer Center
IA COLO
University Hospital, Bordeaux
A Phase Ib/II Clinical Study Evaluating HMPL-453 Tartrate as Monotherapy and in Combination With Chemotherapy or Toripalimab in Advanced Solid Tumors
Hutchmed
Hepatocellular
The University of Hong Kong
NARFI
University Hospital, Bordeaux
GRECCAR 5
University Hospital, Bordeaux
Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator
Novartis
GRECCAR12
University Hospital, Bordeaux
LEAP-012
Merck Sharp & Dohme LLC
Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma
National Cancer Centre, Singapore
Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients
Trishula Therapeutics, Inc.
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
M.D. Anderson Cancer Center
A Trial of mFOLFIRI With MEK162 in Patients With Advanced RAS (HRAS, NRAS, or KRAS) Positive Metastatic Colorectal Cancers
University of Utah
Safety and Pharmacokinetics of Recombinant Anti-EGFr Antibody in Patients With Metastatic Colorectal Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
NABPLAGEMD
HonorHealth Research Institute
COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies
Compugen Ltd
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors
Cybrexa Therapeutics
Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma Patients
Hutchmed